14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Novel approaches to map small molecule-target interactions.
Max Planck Institute of Molecular Physiology
Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEd prenyl binding site.
Max Planck Institute of Molecular Physiology
Charting, navigating, and populating natural product chemical space for drug discovery.
Max Planck Institute of Molecular Physiology
Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH.
Max Planck Institute of Molecular Physiology
Using small molecules to target protein phosphatases.
Max Planck Institute of Molecular Physiology
Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.
Max Planck Institute of Molecular Physiology
Small molecule WDR5 inhibitors down-regulate lncRNA expression.
Max Planck Institute of Molecular Physiology
Rational design and evaluation of 2-((pyrrol-2-yl)methylene)thiophen-4-ones as RNase L inhibitors.
Max Planck Institute of Molecular Physiology
Development of Macrocyclic PRMT5-Adaptor Protein Interaction Inhibitors.
Max Planck Institute of Molecular Physiology
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation.
Max Planck Institute of Molecular Physiology
Discovery of Dihydro-1,4-Benzoxazine Carboxamides as Potent and Highly Selective Inhibitors of Sirtuin-1.
Max Planck Institute of Molecular Physiology
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket.
Max Planck Institute of Molecular Physiology
Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors.
Max Planck Institute of Molecular Physiology
